NEWS

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform 08/22/2023
Foundery Announces Initial Close of Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies
Foundery Announces Initial Close of Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies 08/22/2023
MindRhythm Announces Publication in JAMA Network Open of Novel Headset for Return to Play Decisions in Concussion
MindRhythm Announces Publication in JAMA Network Open of Novel Headset for Return to Play Decisions in Concussion 08/11/2023
Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death
Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death 08/11/2023
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction 08/08/2023
Scalable Care Inc signs landmark license agreement with UCSF to commercialize evidence-based mental health resources
Scalable Care Inc signs landmark license agreement with UCSF to commercialize evidence-based mental health resources 07/19/2023
BeeKeeperAI Raises $12.1 Million Series A to Accelerate AI Development on Privacy Protected Healthcare Data
BeeKeeperAI Raises $12.1 Million Series A to Accelerate AI Development on Privacy Protected Healthcare Data 06/29/2023
Erasca Granted FDA Orphan Drug Designation for CNS-Penetrant EGFR Inhibitor ERAS-801 for the Treatment of Malignant Glioma
Erasca Granted FDA Orphan Drug Designation for CNS-Penetrant EGFR Inhibitor ERAS-801 for the Treatment of Malignant Glioma 06/23/2023
MindRhythm Announces First Patient Enrolled in Pivotal Study of Novel Harmony™ Device for Rapid Detection of Stroke
MindRhythm Announces First Patient Enrolled in Pivotal Study of Novel Harmony™ Device for Rapid Detection of Stroke 06/22/2023
Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis
Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis 06/20/2023
Neurona Therapeutics Presents One-Year Data on the First Patient Treated with NRTX-1001 Cell Therapy in an Ongoing Phase I/II Trial for Drug-resistant Focal Epileps
Neurona Therapeutics Presents One-Year Data on the First Patient Treated with NRTX-1001 Cell Therapy in an Ongoing Phase I/II Trial for Drug-resistant Focal Epileps 06/20/2023
Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting 06/07/2023
Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection
Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection 06/04/2023
UCSF NewCo Vevo Therapeutics has been Selected to Join the AWS Startups Generative AI Accelerator
UCSF NewCo Vevo Therapeutics has been Selected to Join the AWS Startups Generative AI Accelerator 05/31/2023
Pionyr Immunotherapeutics’ Phase 1a Study of TREM1-targeting Antibody PY159 for the Treatment of Solid Tumors Featured at ASCO 2023
Pionyr Immunotherapeutics’ Phase 1a Study of TREM1-targeting Antibody PY159 for the Treatment of Solid Tumors Featured at ASCO 2023 05/30/2023